American Research & Management Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $356K | Hold |
2,654
| – | – | 0.1% | 95 |
|
|
2022
Q2 | $406K | Sell |
2,654
-75
| -3% | -$11.5K | 0.1% | 93 |
|
|
2022
Q1 | $442K | Sell |
2,729
-204
| -7% | -$29.6K | 0.1% | 95 |
|
|
2021
Q4 | $397K | Buy |
2,933
+22
| +0.8% | +$2.6K | 0.09% | 103 |
|
|
2021
Q3 | $314K | Sell |
2,911
-200
| -6% | -$22.9K | 0.07% | 112 |
|
|
2021
Q2 | $350K | Buy |
3,111
+550
| +21% | +$61.9K | 0.08% | 109 |
|
|
2021
Q1 | $277K | Sell |
2,561
-652
| -20% | -$69.7K | 0.07% | 118 |
|
|
2020
Q4 | $344K | Buy |
3,213
+1
| +0% | +$96 | 0.09% | 110 |
|
|
2020
Q3 | $281K | Sell |
3,212
-125
| -4% | -$11.8K | 0.08% | 108 |
|
|
2020
Q2 | $328K | Sell |
3,337
-50
| -1% | -$4.4K | 0.1% | 97 |
|
|
2020
Q1 | $258K | Sell |
3,387
-50
| -1% | -$4.26K | 0.1% | 102 |
|
|
2019
Q4 | $304K | Sell |
3,437
-150
| -4% | -$12.5K | 0.09% | 110 |
|
|
2019
Q3 | $272K | Buy |
3,587
+100
| +3% | +$6.86K | 0.08% | 117 |
|
|
2019
Q2 | $254K | Sell |
3,487
-100
| -3% | -$7.86K | 0.08% | 123 |
|
|
2019
Q1 | $289K | Buy |
3,587
+2,037
| +131% | +$167K | 0.08% | 120 |
|
|
2018
Q4 | $143K | Sell |
1,550
-100
| -6% | -$8.79K | 0.05% | 131 |
|
|
2018
Q3 | $156K | Sell |
1,650
-100
| -6% | -$9.48K | 0.05% | 133 |
|
|
2018
Q2 | $162K | Sell |
1,750
-107
| -6% | -$10.4K | 0.06% | 115 |
|
|
2018
Q1 | $176K | Sell |
1,857
-140
| -7% | -$15.4K | 0.06% | 122 |
|
|
2017
Q4 | $193K | Buy |
1,997
+110
| +6% | +$10.4K | 0.06% | 124 |
|
|
2017
Q3 | $168K | Hold |
1,887
| – | – | 0.05% | 120 |
|
|
2017
Q2 | $137K | Hold |
1,887
| – | – | 0.05% | 124 |
|
|
2017
Q1 | $123K | Sell |
1,887
-893
| -32% | -$56.1K | 0.04% | 117 |
|
|
2016
Q4 | $174K | Hold |
2,780
| – | – | 0.06% | 117 |
|
|
2016
Q3 | $175K | Sell |
2,780
-147
| -5% | -$9.52K | 0.06% | 108 |
|
|
2016
Q2 | $181K | Hold |
2,927
| – | – | 0.07% | 106 |
|
|
2016
Q1 | $167K | Hold |
2,927
| – | – | 0.07% | 109 |
|
|
2015
Q4 | $173K | Sell |
2,927
-89
| -3% | -$5.13K | 0.07% | 110 |
|
|
2015
Q3 | $164K | Hold |
3,016
| – | – | 0.07% | 112 |
|
|
2015
Q2 | $203K | Sell |
3,016
-754
| -20% | -$49.2K | 0.08% | 108 |
|
|
2015
Q1 | $221K | Hold |
3,770
| – | – | 0.09% | 105 |
|
|
2014
Q4 | $247K | Hold |
3,770
| – | – | 0.09% | 99 |
|
|
2014
Q3 | $218K | Hold |
3,770
| – | – | 0.08% | 107 |
|
|
2014
Q2 | $213K | Hold |
3,770
| – | – | 0.07% | 109 |
|
|
2014
Q1 | $194K | Hold |
3,770
| – | – | 0.07% | 116 |
|
|
2013
Q4 | $199K | Sell |
3,770
-100
| -3% | -$4.92K | 0.07% | 115 |
|
|
2013
Q3 | $173K | Hold |
3,870
| – | – | 0.07% | 116 |
|
|
2013
Q2 | $160K | Buy |
+3,870
| New | +$169K | 0.06% | 116 |
|
Other funds holding ABBV
American Research & Management Company's ABBV Position: Q3 2022 in Review
American Research & Management Company held its AbbVie (ABBV) position steady in Q3 2022 at 2,654 shares worth $356K. The position accounts for 0.1% of the portfolio, ranked #95.
American Research & Management Company first reported a position in ABBV in Q2 2013 and has held it in 38 quarters since. The position peaked at $442K in Q1 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- American Research & Management Company held 2,654 shares of AbbVie worth $356K as of Q3 2022.
- American Research & Management Company left its AbbVie share count unchanged in Q3 2022.
- AbbVie made up 0.1% of American Research & Management Company's portfolio in Q3 2022, its #95 holding.
- American Research & Management Company first reported a position in AbbVie in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's AbbVie position peaked at $442K in Q1 2022.
- 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.